China suffers a heavy burden of SCLC and an increasing trend for ICIs therapy.
← all excerpts
Tislelizumab-induced type 1 diabetic ketoacidosis in a patient with small cell lung cancer: a case report.
1
—
—
China suffers a heavy burden of SCLC and an increasing trend for ICIs therapy.